Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

US Army
Moodys
Argus Health
QuintilesIMS
Queensland Health
Colorcon
Express Scripts
Accenture
Daiichi Sankyo
Johnson and Johnson

Generated: August 21, 2017

DrugPatentWatch Database Preview

NORTREL 1/35-21 Drug Profile

« Back to Dashboard

What is the patent landscape for Nortrel 1/35-21, and what generic Nortrel 1/35-21 alternatives are available?

Nortrel 1/35-21 is a drug marketed by Barr and is included in one NDA.

The generic ingredient in NORTREL 1/35-21 is ethinyl estradiol; norethindrone. There are twenty-six drug master file entries for this compound. Twenty-two suppliers are listed for this compound. Additional details are available on the ethinyl estradiol; norethindrone profile page.

Summary for Tradename: NORTREL 1/35-21

Patents:0
Applicants:1
NDAs:1
Suppliers / Packagers: see list1
Bulk Api Vendors: see list4
Patent Applications: see list2
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:NORTREL 1/35-21 at DailyMed

Pharmacology for Tradename: NORTREL 1/35-21

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Barr
NORTREL 1/35-21
ethinyl estradiol; norethindrone
TABLET;ORAL-21072693-001Feb 28, 1992ABRXNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Chinese Patent Office
Johnson and Johnson
Moodys
QuintilesIMS
Dow
US Department of Justice
Federal Trade Commission
Baxter
McKinsey
Accenture

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot